Suspected non-Alzheimer disease pathophysiology — concept and controversyClifford R. Jack, Stephanie J. B. Vos, David S. Knopman et al.|Nature Reviews Neurology|2016Cited by 299
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical SpectrumWillemijn J. Jansen, Lars Frings, Henryk Barthel et al.|JAMA Neurology|2022Cited by 281
Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomicsBetty M. Tijms, Pieter Jelle Visser, Johan Gobom et al.|Brain|2020Cited by 221
Inflammatory biomarkers in Alzheimer's disease plasmaAngharad R. Morgan, B. Paul Morgan, Samuel Touchard et al.|Alzheimer s & Dementia|2019Cited by 207
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levelsShengjun Hong, Lars Bertram, Valerija Dobričić et al.|Alzheimer s & Dementia|2021Cited by 43